Evidence map›Paper›PMID 31658860›Full record

Observational studyJournal of the American Heart Association2019

Early Discontinuation of P2Y

Daniel E Harris, Arron Lacey, Ashley Akbari, Daniel R Obaid, Dave A Smith, Geraint H Jenkins, James P Barry, Mike B Gravenor, Julian P Halcox

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Early Discontinuation of P2YJournal of the American Heart Association · 2019
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniel E HarrisSwansea University Medical School Swansea UK.
Arron LaceySwansea University Medical School Swansea UK.
Ashley AkbariSwansea University Medical School Swansea UK.
Daniel R ObaidSwansea University Medical School Swansea UK.
Dave A SmithSwansea Bay University Health Board Swansea UK.
Geraint H JenkinsSwansea Bay University Health Board Swansea UK.
James P BarrySwansea Bay University Health Board Swansea UK.
Mike B GravenorSwansea University Medical School Swansea UK.
Julian P HalcoxSwansea University Medical School Swansea UK.
Swansea Bay University Health Board · GBSwansea University · GBHealth Data Research UK · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Early discontinuation of P2Y

Indexed as

Medication AdherencePercutaneous Coronary InterventionAgedAged, 80 and overAge FactorsClopidogrelCohort StudiesDrug PrescriptionsFemaleHemorrhageHumansHypertensionMaleMiddle AgedPurinergic P2Y Receptor AntagonistsRenal Insufficiency, ChronicClopidogrelPurinergic P2Y Receptor Antagonistsadherenceclopidogreldischarge therapydiscontinuationpercutaneous coronary intervention

Identifiers

PMID31658860
PMCPMC6898825
OpenAlexW2982549493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.